Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lance A Sloan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Diabetes|July 19, 2019
Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effectsLance A Sloan
Diabetes Spectrum : a Publication of the American Diabetes Association|February 17, 2025
Diabetes and Glucose Management in People on HemodialysisShubham Agarwal, Julia K Mader, Giuliana Arevalo, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 13, 2026
Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USAMichael G Nanna, Lance A Sloan, Ann Marie Navar, et al.
International Journal of Molecular Sciences|May 27, 2026
Physical Exercise Counteracts Impaired Cognition by Improving Mitochondrial FunctionPedro Maciel, Caroline Barbalho Lamas, Adriano Cressoni Araújo, et al.
JACC. Advances|February 17, 2026
Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and DesignJorge Plutzky, Pam R Taub, Deepak L Bhatt, et al.
Diabetes Care|June 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone TreatmentRalph A DeFronzo, Vivian Fonseca, Vanita R Aroda, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Diabetes|July 19, 2019
Review of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effectsLance A Sloan
Diabetes Spectrum : a Publication of the American Diabetes Association|February 17, 2025
Diabetes and Glucose Management in People on HemodialysisShubham Agarwal, Julia K Mader, Giuliana Arevalo, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 13, 2026
Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USAMichael G Nanna, Lance A Sloan, Ann Marie Navar, et al.
International Journal of Molecular Sciences|May 27, 2026
Physical Exercise Counteracts Impaired Cognition by Improving Mitochondrial FunctionPedro Maciel, Caroline Barbalho Lamas, Adriano Cressoni Araújo, et al.
JACC. Advances|February 17, 2026
Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and DesignJorge Plutzky, Pam R Taub, Deepak L Bhatt, et al.
Diabetes Care|June 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone TreatmentRalph A DeFronzo, Vivian Fonseca, Vanita R Aroda, et al.
Pageof 1